Vunakizumab Combined With Recaticimab in Subjects With Moderate to Severe Plaque Psoriasis and Dyslipidemia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
The aim is to evaluate the safety and efficacy of vunakizumab combined with recaticimab versus vunakizumab combined with placebo in the treatment of plaque psoriasis with dyslipidemia.
Epistemonikos ID: 3ae092251aef8556df9571c4e8945962d0bcc2f9
First added on: Jan 29, 2026